Real-life small airway outcomes in severe asthma patients receiving biologic therapies

Rory Chan; Chris RuiWen Kuo; Brian Lipworth

doi:10.1016/j.jaip.2021.01.029

Real-life small airway outcomes in severe asthma patients receiving biologic therapies

Rory Chan, Chris RuiWen Kuo, Brian Lipworth (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

168 Downloads (Pure)

Abstract

FEF_25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe asthma patients receiving biologics. Impulse oscillometry (IOS) can be useful as an adjunct, particularly in those with baseline IOS-defined SAD.

Original language	English
Pages (from-to)	2907-2909
Number of pages	3
Journal	The Journal of Allergy and Clinical Immunology: In Practice
Volume	9
Issue number	7
Early online date	2 Feb 2021
DOIs	https://doi.org/10.1016/j.jaip.2021.01.029
Publication status	Published - Jul 2021

Keywords

small airways dysfunction
severe refractory asthma
omalizumab
mepolizumab
benralizumab
impulse oscillometry
FEF25-75

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2021.01.029Licence: Elsevier User Licence

Author Accepted ManuscriptAccepted author manuscript, 250 KB

Cite this

@article{0644239685c7423a88ec6fddd1518f4c,

title = "Real-life small airway outcomes in severe asthma patients receiving biologic therapies",

abstract = "FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe asthma patients receiving biologics. Impulse oscillometry (IOS) can be useful as an adjunct, particularly in those with baseline IOS-defined SAD. ",

keywords = "small airways dysfunction, severe refractory asthma, omalizumab, mepolizumab, benralizumab, impulse oscillometry, FEF25-75",

author = "Rory Chan and Kuo, {Chris RuiWen} and Brian Lipworth",

note = "No funding",

year = "2021",

month = jul,

doi = "10.1016/j.jaip.2021.01.029",

language = "English",

volume = "9",

pages = "2907--2909",

journal = "The Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "7",

}

TY - JOUR

T1 - Real-life small airway outcomes in severe asthma patients receiving biologic therapies

AU - Chan, Rory

AU - Kuo, Chris RuiWen

AU - Lipworth, Brian

N1 - No funding

PY - 2021/7

Y1 - 2021/7

N2 - FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe asthma patients receiving biologics. Impulse oscillometry (IOS) can be useful as an adjunct, particularly in those with baseline IOS-defined SAD.

AB - FEF25-75 should be incorporated to assess improvement in small airways dysfunction (SAD) for severe asthma patients receiving biologics. Impulse oscillometry (IOS) can be useful as an adjunct, particularly in those with baseline IOS-defined SAD.

KW - small airways dysfunction

KW - severe refractory asthma

KW - omalizumab

KW - mepolizumab

KW - benralizumab

KW - impulse oscillometry

KW - FEF25-75

UR - http://www.scopus.com/inward/record.url?scp=85101402408&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2021.01.029

DO - 10.1016/j.jaip.2021.01.029

M3 - Article

C2 - 33545398

SN - 2213-2198

VL - 9

SP - 2907

EP - 2909

JO - The Journal of Allergy and Clinical Immunology: In Practice

JF - The Journal of Allergy and Clinical Immunology: In Practice

IS - 7

ER -

Real-life small airway outcomes in severe asthma patients receiving biologic therapies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this